Ads
related to: pfizer drug information phone number
Search results
Results From The WOW.Com Content Network
Bococizumab (USAN; [1] development code RN316 [2]) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. [3] Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."
Pages in category "Drugs developed by Pfizer" The following 200 pages are in this category, out of approximately 240 total. ... Contact Wikipedia; Code of Conduct;
Between 2007 and 2010, Pfizer spent $3.3 million on investigations and legal fees and recovered about $5.1 million, and had another $5 million of pending recoveries from civil lawsuits against makers of counterfeit prescription drugs. Pfizer has hired customs and narcotics experts worldwide to track down fakes and assemble evidence that can be ...
For premium support please call: 800-290-4726 more ways to reach us
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move ...
A new drug application (NDA) for the approval of apixaban was submitted to the US Food and Drug Administration (FDA) by Bristol-Myers Squibb (BMS) and Pfizer jointly after the conclusion of the ARISTOTLE clinical trial in 2011. [26] [12] Apixaban was approved for the prevention of stroke in people with atrial fibrillation in December 2012.
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. [1] Today the remainder of the company is owned by Pfizer.
The U.S. Food and Drug Administration has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease, the company said on Friday. The drug, branded as Litfulo, has been approved ...